Inhibitors of Factor VIII in Hemophilia [5]

New England Journal of Medicine

Volumn 361, Issue 3, 2009, Pages 309-

  Eckhardt, Corien L ^a   Kamphuisen, Pieter W ^a   Fijnvandraat, Karin ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING INHIBITOR;

AGE DISTRIBUTION; DISEASE SEVERITY; GROUPS BY AGE; HAPLOTYPE; HEMOPHILIA; HUMAN; LETTER; MISSENSE MUTATION; NEGRO; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; EPIDEMIOLOGY; GENETICS; HEMOPHILIA A; NOTE;

BLOOD COAGULATION FACTOR INHIBITORS; CONFOUNDING FACTORS (EPIDEMIOLOGY); FACTOR VIII; HAPLOTYPES; HEMOPHILIA A; HUMANS; MUTATION, MISSENSE;

EID: 67650886236     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. Eckhardt CL, Menke LA, Van Ommen CH, et al. Intensive peri-operative use of factor VIII and the Arg593→Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A. J Thromb Haemost 2009;7:930-7.